Protection from cerebral ischemia by inhibition of TGFβ-activated kinase.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Experimental Neurology

• Publication date

  2012-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.expneurol.2012.05.019PMID 22683931PMCID PMC3418439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute inhibition of TAK1 protects against neuronal death in cerebral ischemia

  2011cited by this paper
• Functional recovery in aging mice after experimental stroke.

  2011cited by this paper
• Role of 5′-Adenosine Monophosphate-Activated Protein Kinase in Cell Survival and Death Responses in Neurons

  2011cited by this paper
• A new look at glutamate and ischemia: NMDA agonist improves long-term functional outcome in a rat model of stroke.

  2011cited by this paper
• Mitochondria, oxidative metabolism and cell death in stroke.

  2010cited by this paper
• Resistin Up-Regulates COX-2 Expression via TAK1-IKK-NF-κB Signaling Pathway

  2010cited by this paper
• Effects of AMP-Activated Protein Kinase in Cerebral Ischemia

  2010cited by this paper
• Inhibition of the JNK/AP-1 pathway reduces neuronal death and improves behavioral outcome after neonatal hypoxic-ischemic brain injury.

  2010cited by this paper
• A role for NRAGE in NF-κB activation through the non-canonical BMP pathway

  2010cited by this paper
• Adenosine monophosphate activated protein kinase inhibition is protective in both sexes after experimental stroke.

  2010cited by this paper
• Icariin attenuates lipopolysaccharide-induced microglial activation and resultant death of neurons by inhibiting TAK1/IKK/NF-kappaB and JNK/p38 MAPK pathways.

  2010cited by this paper
• JNK inhibition and inflammation after cerebral ischemia.

  2010cited by this paper
• Effects of Metformin in Experimental Stroke

  2010cited by this paper
• Siva1 is a XIAP-interacting protein that balances NFκB and JNK signalling to promote apoptosis

  2009cited by this paper
• Alternate Pathways Preserve Tumor Necrosis Factor-&agr; Production After Nuclear Factor-&kgr;B Inhibition in Neonatal Cerebral Hypoxia–Ischemia

  2009cited by this paper
• TNF-Like Weak Inducer of Apoptosis (TWEAK) Activates Proinflammatory Signaling Pathways and Gene Expression through the Activation of TGF-β-Activated Kinase 11

  2009cited by this paper
• Transforming Growth Factor β-activated Kinase 1 (TAK1) Kinase Adaptor, TAK1-binding Protein 2, Plays Dual Roles in TAK1 Signaling by Recruiting Both an Activator and an Inhibitor of TAK1 Kinase in Tumor Necrosis Factor Signaling Pathway*

  2009cited by this paper
• Inflammation as a therapeutic target in acute ischemic stroke treatment.

  2009cited by this paper
• Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1.

  2009cited by this paper
• Protein Phosphatase 2A Is a Negative Regulator of Transforming Growth Factor-β1-induced TAK1 Activation in Mesangial Cells*

  2008cited by this paper
• TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice

  2008cited by this paper
• TAK1 Regulates Reactive Oxygen Species and Cell Death in Keratinocytes, Which Is Essential for Skin Integrity*

  2008cited by this paper
• Cyclooxygenase inhibition in ischemic brain injury.

  2008cited by this paper
• The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner

  2008cited by this paper
• Neuroprotective Effects of Adenosine Monophosphate-Activated Protein Kinase Inhibition and Gene Deletion in Stroke

  2007cited by this paper
• Mammalian TAK1 Activates Snf1 Protein Kinase in Yeast and Phosphorylates AMP-activated Protein Kinase in Vitro*

  2006cited by this paper
• TAK1 Is a Master Regulator of Epidermal Homeostasis Involving Skin Inflammation and Apoptosis*

  2006cited by this paper
• Dissecting the Role of 5′-AMP for Allosteric Stimulation, Activation, and Deactivation of AMP-activated Protein Kinase*

  2006cited by this paper
• Protein Phosphatase 6 Down-regulates TAK1 Kinase Activation in the IL-1 Signaling Pathway*

  2006cited by this paper
• Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'

  2006cited by this paper
• Essential function for the kinase TAK1 in innate and adaptive immune responses

  2005cited by this paper
• Simultaneous Blockade of NFκB, JNK, and p38 MAPK by a Kinase-inactive Mutant of the Protein Kinase TAK1 Sensitizes Cells to Apoptosis and Affects a Distinct Spectrum of Tumor Necrosis Target Genes*

  2005cited by this paper
• Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction

  2005cited by this paper
• Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis factor [corrected] target genes.

  2005cited by this paper
• Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway.

  2003cited by this paper
• Tumor Necrosis Factor-α-induced IKK Phosphorylation of NF-κB p65 on Serine 536 Is Mediated through the TRAF2, TRAF5, and TAK1 Signaling Pathway*

  2003cited by this paper
• A Resorcylic Acid Lactone, 5Z-7-Oxozeaenol, Prevents Inflammation by Inhibiting the Catalytic Activity of TAK1 MAPK Kinase Kinase*

  2003cited by this paper
• IAP Suppression of Apoptosis Involves Distinct Mechanisms: the TAK1/JNK1 Signaling Cascade and Caspase Inhibition

  2002cited by this paper
• Intravenous TAT–Bcl‐Xl is protective after middle cerebral artery occlusion in mice

  2002cited by this paper
• TAK1 mediates lipopolysaccharide-induced RANTES promoter activation in BV-2 microglial cells.

  2002cited by this paper
• Phosphorylation‐dependent activation of TAK1 mitogen‐activated protein kinase kinase kinase by TAB1

  2000cited by this paper
• The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway

  1999cited by this paper
• Molecular Pathology of Cerebral Ischemia: Delayed Gene Expression and Strategies for Neuroprotection a

  1997cited by this paper
• TAB1: An Activator of the TAK1 MAPKKK in TGF-β Signal Transduction

  1996cited by this paper
• TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction.

  1996cited by this paper
• Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction

  1995cited by this paper
• 5′-AMP Activates the AMP-activated Protein Kinase Cascade, and Ca2+/Calmodulin Activates the Calmodulin-dependent Protein Kinase I Cascade, via Three Independent Mechanisms (*)

  1995cited by this paper

• TAK1 at the crossroads of multiple regulated cell death pathways: from molecular mechanisms to human diseases

  2025cites this paper
• USP43 promotes cerebral ischemia–reperfusion injury via activation of TAK1

  2025cites this paper
• Ketogenic diet and calorie-restricted diet attenuate ischemic brain injury via UBR4 and downstream CamkⅡ/TAK1/JNK signaling

  2023cites this paper
• Regulated necrosis pathways: a potential target for ischemic stroke

  2023cites this paper
• Receptor-interacting protein kinase 2 (RIPK2) profoundly contributes to post-stroke neuroinflammation and behavioral deficits with microglia as unique perpetrators

  2023cites this paper
• IRAK4 exacerbates traumatic brain injury via activation of TAK1 signaling pathway.

  2022cites this paper
• TAK1 blockade as a therapy for retinal neovascularization.

  2022cites this paper
• Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization

  2022cites this paper
• TAK1: a potential therapeutic target for retinal neovascularization

  2021cites this paper
• A high-throughput screening to identify small molecules that suppress huntingtin promoter activity or activate huntingtin-antisense promoter activity

  2021cites this paper
• Receptors, channel proteins, and enzymes involved in microglia-mediated neuroinflammation and treatments by targeting microglia in ischemic stroke.

  2021cites this paper
• Inhibition of TGFβ-activated kinase 1 promotes inflammation-resolving microglial/macrophage responses and recovery after stroke in ovariectomized female mice.

  2021cites this paper
• TBC1Domain Family Member 25 deficiency aggravates cerebral ischemia‐reperfusion injury via TAK1‐JNK/p38 pathway

  2021cites this paper
• Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent Manner

  2021cites this paper
• TAK1 mediates neuronal pyroptosis in early brain injury after subarachnoid hemorrhage

  2021cites this paper
• Sex-Specific Differences in Autophagic Responses to Experimental Ischemic Stroke

  2021cites this paper
• TAK1 signaling is a potential therapeutic target for pathological angiogenesis

  2021cites this paper
• Post-Stroke Social Isolation Reduces Cell Proliferation in the Dentate Gyrus and Alters miRNA Profiles in the Aged Female Mice Brain

  2020cites this paper
• CARD3 Promotes Cerebral Ischemia‐Reperfusion Injury Via Activation of TAK1

  2020cites this paper
• Transforming Growth Factor Beta-Activated Kinase 1–Dependent Microglial and Macrophage Responses Aggravate Long-Term Outcomes After Ischemic Stroke

  2020influential citation
• MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo

  2020cites this paper
• Microglial-specific depletion of TAK1 is neuroprotective in the acute phase after ischemic stroke

  2020cites this paper
• MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo

  2019cites this paper
• Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases.

  2019cites this paper
• Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial cell dysfunction and occurs during multiple sclerosis pathophysiology

  2019cites this paper
• Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosis

  2019cites this paper
• Myeloid-specific TAK1 deletion results in reduced brain monocyte infiltration and improved outcomes after stroke

  2018cites this paper
• The NLRP3 Inflammasome: A Possible Therapeutic Target for Treatment of Stroke

  2018cites this paper
• Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertension

  2018cites this paper
• NG25, an inhibitor of transforming growth factor-β-activated kinase 1, ameliorates neuronal apoptosis in neonatal hypoxic-ischemic rats

  2017cites this paper
• Role of glycogen synthase kinase 3 in ischemia‐induced blood–brain barrier disruption in aged female rats

  2017cites this paper
• The incidence of stroke increases substantially with aging, and around one-third of ischemic strokes occur in elderly

  2017cites this paper
• TGF-β Down-regulates Apolipoprotein M Expression through the TAK-1-JNK-c-Jun Pathway in HepG2 Cells

  2017cites this paper
• Cooperation of Genomic and Rapid Nongenomic Actions of Estrogens in Synaptic Plasticity

  2016cites this paper
• Calcium/calmodulin‐dependent protein kinase kinase β is neuroprotective in stroke in aged mice

  2016cites this paper
• Inhibition of glycogen synthase kinase-3β enhances cognitive recovery after stroke: the role of TAK1

  2015influential citation
• TGFβ-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage*

  2015cites this paper
• TAK1 inhibition-induced RIP1-dependent apoptosis in murine macrophages relies on constitutive TNF-α signaling and ROS production

  2015cites this paper
• TAK1 Mediates TGF beta-1 Responses in Gingival Fibroblasts

  2014cites this paper
• An ASK1-p38 signalling pathway mediates hydrogen peroxide-induced toxicity in NG108-15 neuronal cells.

  2013cites this paper
• Fetal brain genomic reprogramming following asphyctic preconditioning

  2013cites this paper
• TAK1 inhibition for treatment of cerebral ischemia.

  2013influential citation
• Function of the master energy regulator adenosine monophosphate‐activated protein kinase in stroke

  2013cites this paper
• Inhibition of transforming growth factor beta-activated kinase 1 confers neuroprotection after traumatic brain injury in rats.

  2013cites this paper
• Exploring molecular mechanism underlying Chinese medicine syndrome: A study on correlation between Chinese medicine syndrome and biomarkers for ischemic stroke

  2013cites this paper
• TAK1: Kinase at the Crossroads

  2012cites this paper